Hubei Guangji Pharmaceutical Co.,Ltd.’s Net Profit Dropped 40.8% in First Quarter of 2022

Hubei Guangji Pharmaceutical Co.,Ltd. (湖北广济药业股份有限公司) (000952.SZ) reported a net profit of 7.7 million yuan in the first quarter of 2022, down 40.8% year-on-year.

Meanwhile, the company posted 178.9 million yuan in revenue, up 1.4% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 858.1 million yuan in total liabilities, with a liability-to-asset ratio of 37%.